Sandoz International GmbH
Division of Novartis AG
www.sandoz.com
Latest From Sandoz International GmbH
Deal Watch: Aevi Options AstraZeneca Antibody For Rare Disease
Amgen’s Future Looks Brighter After Ruling Lifts Threat Of Enbrel Copycat
Markets are re-assessing Amgen’s long-term value after a US judge upheld two patents relating to Amgen's blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis and allowing investors to focus now on the pharma’s promising pipeline.
Coherus Set Sights On Taking Fifth Of US Pegfilgrastim Market
Having made a strong start with sales of over $120m in its first six months on the market, Coherus believes its Udenyca biosimilar could end 2019 with more than a fifth of the US pegfilgrastim market by volume.
Amgen’s Nonconformist Position On Biosimilar Payment Policy Reflects Market Strategy
Company objects to legislative proposals that would enhance Medicare Part B reimbursement for biosimilars to boost uptake, even as it launches its first biosimilars in the US market.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Cancer
- Cardiovascular
- Dermatology
- Gynecological, Urological
- Immune Disorders
- Infectious & Viral Diseases
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Sandoz
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Novartis AG
- Sandoz International GMBH
-
Sandoz International GmbH
- Azupharma GMBH
- Biochemie GMBH
- Biochemie GmbH
- Ciba-geigy AG
- Durascan Medical Products AS
- Ebewe Pharma GMBH
- Geneva Pharmaceuticals Inc.
- Hexal AG
- Labinca SA
- Lagap Pharmaceuticals Ltd.
- Oriel Therapeutics Inc.
- Sandoz Canada
- Sandoz Chemicals Corp.
- Sandoz Inc.
- Sandoz KK
- Sandoz Nutrition Corp.
- Sandoz Pharma Ltd.
- Sandoz Pharmaceuticals Corp.
- Sandoz Pharmaceuticals Ltd.
- Sandoz Research Institute
- Senior Management
-
Philippe Deecke, CFO
Richard Francis, Division Head
Isabel Afonso, Head, Global Commercial Operations
Shawn Silvestri, Global Head, Product Dev. - Contact Info
-
Sandoz International GmbH
Phone: (49) 8024 4760
Industriestrasse 25
Holzkirchen, D-83607
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice